Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

STM Medizintechnik GMBH

This article was originally published in Start Up

Executive Summary

Given all of the interest in technologically innovative ways to do colon examinations today, from virtual colonoscopies using computerized tomography to imaging systems contained in small pills that patients swallow, a la Given Imaging Ltd., the technology that Heidelberg, Germany-based STM Medizintechnik GMBH has developed seems hopelessly conventional: yet another variant on a traditional endoscope. But STM officials argue that their device has the look and feel of a device that physicians are already comfortable with, combined with innovative features that solve several of the limitations of traditional endoscopy that led device companies, and their customers, in search of new approaches.
Advertisement

Related Content

invendo medical GMBH
Medical Device Start-Ups in Germany
Given Imaging: A Capsule View of GI Diagnostics' Future
A Gut Feeling

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC090864

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel